Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 4.963
Filter
1.
Internet resource in Portuguese | LIS -Health Information Locator | ID: lis-LISBR1.1-47686

ABSTRACT

O Governo Federal assumiu o compromisso com a população brasileira para garantir a efetividade de ações de enfrentamento da Covid-19 desde o início da pandemia. Foi instituído o Comitê de Operações de Emergência (COE), que produz, de forma integrada entre as secretarias do Ministério da Saúde e a gestão tripartite, uma série de orientações e protocolos que obedecem a critérios técnicos e embasam a gestão da pasta na tomada de decisões estratégicas.


Subject(s)
Coronavirus Infections/prevention & control , Betacoronavirus , Brazil/epidemiology
2.
Internet resource in English, Spanish | LIS -Health Information Locator | ID: lis-LISBR1.1-47687

ABSTRACT

Cuando la región de las Américas reporta 100.000 casos de COVID-19 cada día, la Directora de la Organización Panamericana de la Salud (OPS), Carissa F. Etienne, pidió una fuerte coordinación entre los países, guiar las acciones de sus líderes en evidencia y que las personas se protejan a sí mismas y a los demás.


Subject(s)
Coronavirus Infections/prevention & control , Betacoronavirus , Americas/epidemiology , Use of Scientific Information for Health Decision Making
3.
Washington; Organización Panamericana de la Salud; jul. 7, 2020. 3 p.
Non-conventional in Spanish | LILACS | ID: biblio-1102872

ABSTRACT

La semana pasada se cumplieron seis meses desde que se alertó a la Organización Mundial de la Salud sobre unos casos de "neumonía de causa desconocida" que circulaban en Wuhan. El 16 de enero, la OPS fue la primera oficina regional en emitir una alerta epidemiológica con recomendaciones para prevenir y controlar infecciones.


Subject(s)
Pneumonia, Viral/prevention & control , Pneumonia, Viral/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/epidemiology , Betacoronavirus , Americas/epidemiology
6.
BMC Public Health ; 20(1): 1036, 2020 Jun 30.
Article in English | MEDLINE | ID: mdl-32605549

ABSTRACT

BACKGROUND: Due to the SARS-CoV-2 pandemic, public health interventions have been introduced globally in order to prevent the spread of the virus and avoid the overload of health care systems, especially for the most severely affected patients. Scientific studies to date have focused primarily on describing the clinical course of patients, identifying treatment options and developing vaccines. In Germany, as in many other regions, current tests for SARS-CoV2 are not conducted on a representative basis and in a longitudinal design. Furthermore, knowledge about the immune status of the population is lacking. Nonetheless, these data are needed to understand the dynamics of the pandemic and hence to appropriately design and evaluate interventions. For this purpose, we recently started a prospective population-based cohort in Munich, Germany, with the aim to develop a better understanding of the state and dynamics of the pandemic. METHODS: In 100 out of 755 randomly selected constituencies, 3000 Munich households are identified via random route and offered enrollment into the study. All household members are asked to complete a baseline questionnaire and subjects ≥14 years of age are asked to provide a venous blood sample of ≤3 ml for the determination of SARS-CoV-2 IgG/IgA status. The residual plasma and the blood pellet are preserved for later genetic and molecular biological investigations. For twelve months, each household member is asked to keep a diary of daily symptoms, whereabouts and contacts via WebApp. If symptoms suggestive for COVID-19 are reported, family members, including children < 14 years, are offered a pharyngeal swab taken at the Division of Infectious Diseases and Tropical Medicine, LMU University Hospital Munich, for molecular testing for SARS-CoV-2. In case of severe symptoms, participants will be transferred to a Munich hospital. For one year, the study teams re-visits the households for blood sampling every six weeks. DISCUSSION: With the planned study we will establish a reliable epidemiological tool to improve the understanding of the spread of SARS-CoV-2 and to better assess the effectiveness of public health measures as well as their socio-economic effects. This will support policy makers in managing the epidemic based on scientific evidence.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Coronavirus Infections/transmission , Germany/epidemiology , Humans , Pneumonia, Viral/transmission , Prospective Studies , Research Design
7.
Ital J Pediatr ; 46(1): 87, 2020 Jun 29.
Article in English | MEDLINE | ID: mdl-32600464

ABSTRACT

Since the outbreak of COVID-19 pandemic, the number of cases registered worldwide has risen to over 3 million. While COVID-19 per se does not seem to represent a significant threat to the pediatric population, which generally presents a benign course and a low lethality, the current emergency might negatively affect the care of pediatric patients and overall children welfare. In particular, the fear of contracting COVID-19 may determine a delayed access to pediatric emergency facilities. Present report focuses on the experience of The Children Hospital in Alessandria (northern Italy). The authors document a drop in the number of admissions to the emergency department (A&E) during the lock-down. They will also focus on four emblematic cases of pediatric patients who were seen to our A&E in severe conditions. All these cases share a significant diagnostic delay caused by the parents' reluctance to seek medical attention, seen as a potential risk factor for COVID-19 contagion. None was found positive to all COVID-19 swab or immunologic testing. All in all, our data strongly support the importance of promoting a direct and timely interaction between patients and medical staff, to prevent the fear of COVID-19 from causing more harm than the virus itself.


Subject(s)
Coronavirus Infections/epidemiology , Delayed Diagnosis/statistics & numerical data , Emergency Service, Hospital/statistics & numerical data , Infection Control/organization & administration , Pandemics/statistics & numerical data , Pneumonia, Viral/epidemiology , Child , Child Welfare , Coronavirus Infections/prevention & control , Emergencies/epidemiology , Female , Hospitals, Pediatric , Humans , Italy/epidemiology , Male , Pandemics/prevention & control , Patient Admission/statistics & numerical data , Pediatrics/organization & administration , Pneumonia, Viral/prevention & control , Program Development , Risk Assessment
8.
Public Health Res Pract ; 30(2)2020 Jun 30.
Article in English | MEDLINE | ID: mdl-32601652

ABSTRACT

OBJECTIVES: Our objective is to assess the potential contribution of the Australian Government's mobile smartphone tracing app (COVIDSafe) to the sustained control of coronavirus disease 2019 (COVID-19). STUDY TYPE: Development and analysis of a system dynamics model. METHODS: To define the pandemic context and specify model-building parameters, we searched for literature on COVID-19, its epidemiology in Australia, case finding processes, and factors that might affect community acceptance of the COVIDSafe smartphone app for contact tracing. We then developed a system dynamics model of COVID-19 based on a modified susceptible-exposed-infected-recovered compartmental model structure, using initial pandemic data and published information on virus behaviour to determine parameter values. We applied the model to examine factors influencing the projected trends: the extent of viral testing, community participation in social distancing, and the level of uptake of the COVIDSafe app. RESULTS: Modelling suggests that a second COVID-19 wave will occur if social distancing declines (i.e. if the average number of contacts made by each individual each day increases) and the rate of testing declines. The timing and size of the second wave will depend on the rate of decrease in social distancing and the decline in testing rates. At the app uptake level of approximately 27% (current at 20 May 2020), with a monthly 50% reduction in social distancing (i.e. the average number of contacts per day doubling every 30 days until they reach pre-social distancing rates) and a 5% decline in testing, the app would reduce the projected total number of new cases during April-December 2020 by one-quarter. If uptake reaches the possible maximum of 61%, the reduction could be more than half. CONCLUSIONS: Maintenance of a large-scale testing regimen for COVID-19 and widespread community practice of social distancing are vital. The COVIDSafe smartphone app has the potential to be an important adjunct to testing and social distancing. Depending on the level of community uptake of the app, it could have a significant mitigating effect on a second wave of COVID-19 in Australia.


Subject(s)
Betacoronavirus , Clinical Laboratory Techniques/statistics & numerical data , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Smartphone/statistics & numerical data , Australia , Coronavirus Infections/diagnosis , Humans , Interpersonal Relations , Mobile Applications/statistics & numerical data , Models, Theoretical , Pneumonia, Viral/diagnosis , Public Health , Risk Assessment , Social Distance
9.
Acta Gastroenterol Belg ; 83(2): 340-343, 2020.
Article in English | MEDLINE | ID: mdl-32603060

ABSTRACT

Since January 2020, the Novel Coronavirus Disease 2019 (COVID-19) pandemic has dramatically impacted the world. In March 2020, the COVID-19 epidemic reached Belgium creating uncertainty towards all aspects of life. There has been an impressive capacity and solidarity of all healthcare professionals to acutely reconvert facilities to treat these patients. In the context of liver transplantation (LTx), concerns are raised about organ donation shortage and safety, the ethics of using limited healthcare resources for LTx, selection criteria for LTx during the epidemic and the risk of de novo COVID-19 infection on the waiting list and after LTx. BeLIAC makes several recommendations to try to mitigate the deleterious effect that this epidemic has/will have on donation and LTx, taking into account the available resources, and trying to maximize patients and healthcare professionals' safety.


Subject(s)
Coronavirus Infections , End Stage Liver Disease/surgery , Infection Control/methods , Liver Transplantation/methods , Pandemics , Pneumonia, Viral , Belgium , Betacoronavirus , Coronavirus , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , End Stage Liver Disease/epidemiology , Humans , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission
10.
Acta Gastroenterol Belg ; 83(2): 344-354, 2020.
Article in English | MEDLINE | ID: mdl-32603061

ABSTRACT

Background and aims: With the first wave of the COVID-19 pandemic declining, activities in the gastrointestinal clinic are being recommenced after a period of stringent measures. Since a second COVID-19 wave is not entirely ruled out health care professionals might remain faced with the need to perform endoscopic procedures in patients with a confirmed positive or unknown COVID-19 status. With this report we aim to provide a practical relevant overview of preparation and protective measures for gastroenterologists based on the currently available guidelines and our local experience and results of a national Belgian survey, to guarantee a fast recall of an adequate infection prevention if COVID-19 reoccurs. Methods: From the 23rd of March 2020 and the 13th of May 2020 we performed a Pubmed, Embase and Medline search, resulting in 37 papers on COVID-19 and endoscopy. Additionally, we combined these data with data acquired from the national BSGIE survey amongst Belgian gastroenterologists. Results: Based on 72 completed surveys in both university and non-university hospitals, the results show (1) a dramatic (<20%) or substantial (<50%) decrease of normal daily endoscopy in 74% and 22% of the units respectively, (2) a difference in screening and protective measures between university and non-university hospitals. These findings were subsequently compared with the current guidelines. Conclusion: Based on new data from the BSGIE survey and current guidelines we tried to realistically represent the current COVID-19 trends in protective measures, screening and indications for endoscopy and to provide a practical overview as preparation for a possible second wave.


Subject(s)
Coronavirus Infections/prevention & control , Disease Transmission, Infectious/prevention & control , Endoscopy, Gastrointestinal , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Pandemics/prevention & control , Personal Protective Equipment , Pneumonia, Viral/prevention & control , Belgium , Betacoronavirus , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Gastroenterologists , Humans , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Surveys and Questionnaires
11.
Yonsei Med J ; 61(7): 631-634, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32608207

ABSTRACT

Thirteen patients with coronavirus disease 2019 (COVID-19) visited a university hospital in Seoul before recognizing their disease infections, causing contact with 184 hospital workers. We classified the patients into four risk levels and provided corresponding management measures. At 31 days after the last event, all screening laboratory results were negative, and no symptoms/signs were reported.


Subject(s)
Coronavirus Infections/prevention & control , Disease Outbreaks/prevention & control , Health Personnel/psychology , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Occupational Exposure/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Asymptomatic Infections , Betacoronavirus , Clinical Laboratory Techniques , Coronavirus , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Female , Hospitals, Teaching , Humans , Male , Personal Protective Equipment , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Republic of Korea/epidemiology
12.
MMWR Morb Mortal Wkly Rep ; 69(26): 847-849, 2020 Jul 03.
Article in English | MEDLINE | ID: mdl-32614809

ABSTRACT

On March 26, 2020, Colorado instituted stay-at-home orders to reduce community transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). To inform public health messaging and measures that could be used after reopening, persons with laboratory-confirmed COVID-19 during March 9-26 from nine Colorado counties comprising approximately 80% of the state's population† (Adams, Arapahoe, Boulder, Denver, Douglas, El Paso, Jefferson, Larimer, and Weld) were asked about possible exposures to SARS-CoV-2 before implementation of stay-at-home orders. Among 1,738 persons meeting the inclusion criteria§ in the Colorado Electronic Disease Surveillance System, 600 were randomly selected and interviewed using a standardized questionnaire by telephone. Data collection during April 10-30 included information about demographic characteristics, occupations, and selected activities in the 2 weeks preceding symptom onset. During the period examined, SARS-CoV-2 molecular testing was widely available in Colorado; community transmission was documented before implementation of the stay-at-home order. At least three attempts were made to contact all selected patients or their proxy (for deceased patients, minors, and persons unable to be interviewed [e.g., those with dementia]) on at least 2 separate days, at different times of day. Data were entered into a Research Electronic Data Capture (version 9.5.13; Vanderbilt University) database, and descriptive analyses used R statistical software (version 3.6.3; The R Foundation).


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Environmental Exposure/statistics & numerical data , Pandemics/prevention & control , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Public Health/legislation & jurisprudence , Adult , Colorado/epidemiology , Coronavirus Infections/epidemiology , Female , Humans , Laboratories , Male , Middle Aged , Pneumonia, Viral/epidemiology , Social Isolation
13.
MMWR Morb Mortal Wkly Rep ; 69(26): 825-829, 2020 Jul 03.
Article in English | MEDLINE | ID: mdl-32614815

ABSTRACT

In the United States, approximately 180,000 patients receive mental health services each day at approximately 4,000 inpatient and residential psychiatric facilities (1). SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), can spread rapidly within congregate residential settings (2-4), including psychiatric facilities. On April 13, 2020, two patients were transferred to Wyoming's state psychiatric hospital from a private psychiatric hospital that had confirmed COVID-19 cases among its residents and staff members (5). Although both patients were asymptomatic at the time of transfer and one had a negative test result for SARS-CoV-2 at the originating facility, they were both isolated and received testing upon arrival at the state facility. On April 16, 2020, the test results indicated that both patients had SARS-CoV-2 infection. In response, the state hospital implemented expanded COVID-19 infection prevention and control (IPC) procedures (e.g., enhanced screening, testing, and management of new patient admissions) and adapted some standard IPC measures to facilitate implementation within the psychiatric patient population (e.g., use of modified face coverings). To assess the likely effectiveness of these procedures and determine SARS-CoV-2 infection prevalence among patients and health care personnel (HCP) (6) at the state hospital, a point prevalence survey was conducted. On May 1, 2020, 18 days after the patients' arrival, 46 (61%) of 76 patients and 171 (61%) of 282 HCP had nasopharyngeal swabs collected and tested for SARS-CoV-2 RNA by reverse transcription-polymerase chain reaction. All patients and HCP who received testing had negative test results, suggesting that the hospital's expanded IPC strategies might have been effective in preventing the introduction and spread of SARS-CoV-2 infection within the facility. In congregate residential settings, prompt identification of COVID-19 cases and application of strong IPC procedures are critical to ensuring the protection of other patients and staff members. Although standard guidance exists for other congregate facilities (7) and for HCP in general (8), modifications and nonstandard solutions might be needed to account for the specific needs of psychiatric facilities, their patients, and staff members.


Subject(s)
Coronavirus Infections/prevention & control , Cross Infection/prevention & control , Hospitals, Psychiatric , Mass Screening , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Residential Facilities , Adult , Aged , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Cross Infection/epidemiology , Female , Humans , Male , Middle Aged , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Wyoming/epidemiology
14.
MMWR Morb Mortal Wkly Rep ; 69(26): 836-840, 2020 Jul 03.
Article in English | MEDLINE | ID: mdl-32614816

ABSTRACT

Transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), by asymptomatic and presymptomatic persons poses important challenges to controlling spread of the disease, particularly in congregate settings such as correctional and detention facilities (1). On March 29, 2020, a staff member in a correctional and detention facility in Louisiana developed symptoms† and later had a positive test result for SARS-CoV-2. During April 2-May 7, two additional cases were detected among staff members, and 36 cases were detected among incarcerated and detained persons at the facility; these persons were removed from dormitories and isolated, and the five dormitories that they had resided in before diagnosis were quarantined. On May 7, CDC and the Louisiana Department of Health initiated an investigation to assess the prevalence of SARS-CoV-2 infection among incarcerated and detained persons residing in quarantined dormitories. Goals of this investigation included evaluating COVID-19 symptoms in this setting and assessing the effectiveness of serial testing to identify additional persons with SARS-CoV-2 infection as part of efforts to mitigate transmission. During May 7-21, testing of 98 incarcerated and detained persons residing in the five quarantined dormitories (A-E) identified an additional 71 cases of SARS-CoV-2 infection; 32 (45%) were among persons who reported no symptoms at the time of testing, including three who were presymptomatic. Eighteen cases (25%) were identified in persons who had received negative test results during previous testing rounds. Serial testing of contacts from shared living quarters identified persons with SARS-CoV-2 infection who would not have been detected by symptom screening alone or by testing at a single time point. Prompt identification and isolation of infected persons is important to reduce further transmission in congregate settings such as correctional and detention facilities and the communities to which persons return when released.


Subject(s)
Clinical Laboratory Techniques/methods , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Prisoners/statistics & numerical data , Prisons , Adult , Clinical Laboratory Services , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Female , Humans , Louisiana/epidemiology , Male , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission
15.
Sr Care Pharm ; 35(7): 286-291, 2020 Jul 01.
Article in English | MEDLINE | ID: mdl-32600505

ABSTRACT

Pharmacists across various practice settings are joining the fight against COVID-19, empowered by the resources available through national, governmental and professional organizations. Long-term care pharmacists are instrumental in optimizing medication management and developing policies to reduce the risk of COVID-19 transmission among vulnerable residents.


Subject(s)
Coronavirus Infections/prevention & control , Coronavirus Infections/therapy , Pandemics/prevention & control , Pharmacists , Pneumonia, Viral/prevention & control , Pneumonia, Viral/therapy , Professional Role , Betacoronavirus , Humans
16.
Sr Care Pharm ; 35(7): 331, 2020 Jul 01.
Article in English | MEDLINE | ID: mdl-32600512

ABSTRACT

The Centers for Medicare & Medicaid Services (CMS) and other federal agencies are busy churning out regulations and guidance documents in response to the COVID-19 crisis. CMS now requires plans to waive cost sharing for COVID-19-related immunizations, testing, and treatment and suspend utilization review requirements related to drug-supply limits unless these limits are related to patient safety.


Subject(s)
Coronavirus Infections/diagnosis , Coronavirus Infections/therapy , Medicaid/organization & administration , Medicare/organization & administration , Pneumonia, Viral/diagnosis , Pneumonia, Viral/therapy , Betacoronavirus , Coronavirus Infections/economics , Coronavirus Infections/prevention & control , Drug Utilization , Humans , Pandemics/economics , Pandemics/prevention & control , Pneumonia, Viral/economics , Pneumonia, Viral/prevention & control , United States
17.
Internet resource in Portuguese | LIS -Health Information Locator | ID: lis-LISBR1.1-47654

ABSTRACT

Diante das incertezas e falta de evidências científicas quanto à possibilidade de transmissão do novo coronavírus ao feto por mulheres grávidas diagnosticadas ou com suspeita de covid-19, médicos do Hospital das Clínicas (HC) da Faculdade de Medicina da USP (FMUSP), preparam protocolos de cuidados com os recém-nascidos durante e após o parto.


Subject(s)
Coronavirus Infections/prevention & control , Pneumonia, Viral/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Infant Care , Clinical Protocols , Midwifery
18.
Internet resource in Portuguese | LIS -Health Information Locator | ID: lis-LISBR1.1-47618

ABSTRACT

Em virtude da chegada e propagação do novo coronavírus (COVID-19) no Brasil, o Departamento Científico de Aleitamento Materno da Sociedade Brasileira de Pediatria (SBP) preparou uma nota de alerta aos pediatras sobre a amamentação em mulheres que estejam com suspeita ou infectadas pelo vírus.


Subject(s)
Breast Feeding , Maternal Nutrition , Betacoronavirus , Pneumonia, Viral/prevention & control , Coronavirus Infections/prevention & control
19.
Internet resource in Portuguese | LIS -Health Information Locator | ID: lis-LISBR1.1-47591

ABSTRACT

Em meio a dúvidas e receios sobre como mães e pais devem proceder para garantir a segurança do recém-nascido durante a pandemia do novo coronavírus, a Organização Pan-americana da Saúde/Organização Mundial da Saúde (OPAS/OMS) publicou um guia de recomendações sobre as vacinas BCG e hepatite B.


Subject(s)
Breast Feeding , BCG Vaccine , Hepatitis B Vaccines , Coronavirus Infections/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Milk, Human , Infant, Newborn , Betacoronavirus
20.
Washington; Organización Panamericana de la Salud; jun. 19, 2020. 84 p.
Non-conventional in Spanish | LILACS | ID: biblio-1100377

ABSTRACT

La COVID-19 se ha propagado a los 54 países y territorios de las Américas. Para el 26 de mayo del 2020, los casos y las muertes en América Latina habían sobrepasado los de Europa y Estados Unidos en lo que se refiere al número diario de infecciones por coronavirus notificadas. Para junio, dos de los tres países con el mayor número de casos notificados se encontraban en las Américas, región que se ha convertido en el epicentro de la pandemia. En este informe se expone una visión general de la respuesta de la OPS a la pandemia de COVID-19. Comienza en enero de 2020, cuando la OPS movilizó rápidamente sus expertos y despachó material de laboratorio para la detección molecular del virus hasta el 31 de mayo del 2020. Se presenta un análisis de la situación epidemiológica en las Américas y del impacto de la propagación del virus en los sistemas de salud de América Latina y el Caribe, así como aspectos destacados selectos del trabajo de la OPS en los países y territorios que integran esta organización de salud pública. Se incluyen datos epidemiológicos hasta el 12 de junio del 2020 (salvo que se indique otra cosa) para reflejar con mayor precisión la rápida evolución de la situación. Asimismo, se explica el trabajo de la OPS orientado a detener la propagación del virus SARS-CoV-2 hasta el 31 de mayo del 2020.


Subject(s)
Humans , Pneumonia, Viral/prevention & control , Coronavirus Infections/prevention & control , Coronavirus Infections/epidemiology , Pandemics/prevention & control , Betacoronavirus , Pan American Health Organization , Americas/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL